Skip to content

Understanding how DUX4 causes muscle damage in facioscapulohumeral muscular dystrophy

Professor Peter Zammit and his PhD student are studying how the DUX4 gene affects muscle cells in FSHD, to help find new ways to treat the condition.
Details
Principal Investigator
Professor Peter Zammit
Institute
King's College London
Official title
Deciphering molecular pathology in facioscapulohumeral muscular dystrophy
Duration
Four years
Total cost
£168,382
Conditions
Facioscapulohumeral muscular dystrophy (FSHD)
Year
2025

Background

Facioscapulohumeral muscular dystrophy (FSHD) is linked to a gene called DUX4. This gene is normally switched on only briefly at the very start of human development, when the body is just a few cells. DUX4 helps start growth by turning on other important genes. After that, it’s switched off and stays off in most cells.

In people with FSHD, DUX4 is wrongly switched back on in muscle cells. Because it controls other genes, this can lead to the wrong ones being turned on and this can stop the cell from working properly and cause muscle damage over time.

Genes are parts of DNA that carry instructions for making proteins. Proteins do most of the work in cells. If the wrong genes are active, the cell might make proteins it doesn’t need or stop making ones it does.

Scientists think DUX4 changes how cells read their DNA, without changing the DNA itself. This is called epigenetics. It’s a bit like using sticky notes or highlighters in a book: the words stay the same, but the notes change how you read or use them.

DUX4 may add markers to DNA that change how active certain genes are. But scientists still don’t know which parts of DNA are affected, or how this leads to muscle damage.

Project aims

This project is looking at how DUX4 changes the way muscle cells read their DNA, and how this leads to FSHD. It also looks at another gene called PAX7, which helps muscles grow and repair.

1) How DUX4 changes how DNA is read
The team is studying lab-grown muscle cells with different levels of DUX4. They’ll look at DNA markers that control which genes are turned on or off. This will help show what happens inside cells when DUX4 is active.

2) Are the same genes affected in FSHD?
They’ll check if the same gene changes caused by DUX4 are also found in muscle tissue from people with FSHD. This will help show which changes are linked to the condition.

3) Testing key gene changes
The team will test a few important genes affected by DUX4 to see if they cause or improve muscle problems. This could help find new ways to treat FSHD.

4) Studying PAX7
DUX4 interferes with PAX7, which controls genes for muscle growth and repair. The team thinks PAX7 might also change how DNA is read, like DUX4 does. They’ll study whether PAX7 affects the same or different genes. This could help explain how DUX4 stops muscle cells from working properly.

Why is this research important?

To find better treatments for FSHD, scientists need to understand what’s going wrong in muscle cells. We know that DUX4 plays a big role, but we don’t yet know exactly how.

By learning more about how DUX4 changes the way DNA is read, this research could help find new targets for medicines. That could lead to treatments that slow down or stop the condition from getting worse.

Was this information clear and helpful?

Yes
No
Thanks for your feedback!

We’ve already made great progress.

But there is still so much that needs to be done. Together, we can change the future of muscle wasting conditions. Join us. Today.